Can Mutations in Splicing Enhancers Lead to Disease?
Yes, mutations or alterations in splicing enhancers can lead to a variety of diseases. These mutations can disrupt the normal splicing process, resulting in the production of aberrant proteins that may contribute to disease pathogenesis. For example, certain genetic disorders and cancers have been linked to mutations in splicing enhancer sequences, leading to mis-splicing of critical genes.
